ATE113312T1 - Verfahren zur herstellung eines polypeptids welches als menschlicher neutrophiler chemotaktischer faktor aktiv ist. - Google Patents

Verfahren zur herstellung eines polypeptids welches als menschlicher neutrophiler chemotaktischer faktor aktiv ist.

Info

Publication number
ATE113312T1
ATE113312T1 AT89909925T AT89909925T ATE113312T1 AT E113312 T1 ATE113312 T1 AT E113312T1 AT 89909925 T AT89909925 T AT 89909925T AT 89909925 T AT89909925 T AT 89909925T AT E113312 T1 ATE113312 T1 AT E113312T1
Authority
AT
Austria
Prior art keywords
chemotactic factor
human neutrophil
neutrophil chemotactic
preparing
polypeptide active
Prior art date
Application number
AT89909925T
Other languages
English (en)
Inventor
Masaaki Murasakino Nish Yamada
Ryuji Furuta
Junichi Yamagishi
Kouji Matsushima
University Kanazawa
Original Assignee
Us Gov Health & Human Serv
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv, Dainippon Pharmaceutical Co filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of ATE113312T1 publication Critical patent/ATE113312T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5421—IL-8
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT89909925T 1988-08-29 1989-08-29 Verfahren zur herstellung eines polypeptids welches als menschlicher neutrophiler chemotaktischer faktor aktiv ist. ATE113312T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23774188A 1988-08-29 1988-08-29

Publications (1)

Publication Number Publication Date
ATE113312T1 true ATE113312T1 (de) 1994-11-15

Family

ID=22894964

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89909925T ATE113312T1 (de) 1988-08-29 1989-08-29 Verfahren zur herstellung eines polypeptids welches als menschlicher neutrophiler chemotaktischer faktor aktiv ist.

Country Status (7)

Country Link
US (1) US5401643A (de)
EP (1) EP0431042B1 (de)
JP (1) JP3053631B2 (de)
KR (1) KR100197110B1 (de)
AT (1) ATE113312T1 (de)
DE (1) DE68919085T2 (de)
WO (1) WO1990002178A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652338A (en) 1988-03-16 1997-07-29 The United States Of America As Represented By The Department Of Health And Human Services Neutrophil chemotactic factor
JP4739763B2 (ja) 2002-12-16 2011-08-03 ゲンマブ エー／エス インターロイキン８（ｉｌ−８）に対するヒトモノクローナル抗体
AU2006294868B2 (en) * 2005-09-26 2011-03-03 Coupons, Inc. System and method for augmenting content in electronic documents with links to contextually relevant information
EP3737696A1 (de) 2018-01-12 2020-11-18 Bristol-Myers Squibb Company Kombinationstherapie mit anti-il-8-antikörpern und anti-pd-1-antikörpern zur behandlung von krebs

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4511502A (en) * 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4511503A (en) * 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4897348A (en) * 1983-08-25 1990-01-30 Sri International Recombinant materials and methods for producing human connective tissue-activating peptide-III and analogs thereof
GB2223225B (en) * 1987-11-19 1992-07-08 Sandoz Ltd Neutrophil-activating factor: its production and use in treatment
US5026639A (en) * 1988-01-14 1991-06-25 Nippon Mining Company, Limited Method to improve mRNA translation and use thereof for production of platelet factor-4

Also Published As

Publication number Publication date
KR100197110B1 (ko) 1999-06-15
DE68919085D1 (de) 1994-12-01
US5401643A (en) 1995-03-28
JP3053631B2 (ja) 2000-06-19
EP0431042B1 (de) 1994-10-26
DE68919085T2 (de) 1995-04-06
JPH04500156A (ja) 1992-01-16
EP0431042A1 (de) 1991-06-12
EP0431042A4 (en) 1992-03-11
KR900702031A (ko) 1990-12-05
WO1990002178A1 (en) 1990-03-08

Similar Documents

Publication Publication Date Title
DE68916537T3 (de) Herstellung eines insulinähnlichen, wachstümsfaktor bindenden proteins.
ES8704973A1 (es) Un procedimiento para la preparacion de un peptido.
ES8501979A1 (es) Procedimiento para preparar un concentrado de factor antihemofilico
HUT54213A (en) Process for the enzymatic removal of n-terminal sequence of proteins
ATE84048T1 (de) Peptid, dessen verfahren zur herstellung, sie enthaltende pharmazeutische zusammensetzung und benutzung.
DE59104720D1 (de) Antifungisches polypeptid, verfahren zu seiner herstellung.
ATE131493T1 (de) Polypeptide und polypeptidanaloge mit inhibitorischer aktivität gegenüber menschlicher elastase
ATE149523T1 (de) Verfahren zur herstellung von interferon-alpha-2 kristallen
IL102346A0 (en) Cysteine depleted il-6 muteins
NZ222466A (en) Hexa to deca peptides capable of stimulating the proliferation of myelopoietic stem cells
HU896934D0 (en) Anti-thrombins
NO921829L (no) Nytt polypeptid, samt anti-hiv-medikament fremstilt derav
ATE113312T1 (de) Verfahren zur herstellung eines polypeptids welches als menschlicher neutrophiler chemotaktischer faktor aktiv ist.
ATE146188T1 (de) Substituierungsanaloge von magaininpeptiden
EP0161007A3 (de) Retro-inverso C-Terminal-Hexapeptid-Analoga von der Verbindung P
IE852596L (en) Peptides active on the cns
FI93843C (fi) Menetelmä angiogeenisen tekijän tuottamiseksi
ATE120758T1 (de) Peptide, deren verwendung als hemmer gegen entwicklung von t-lymphocyten und wirksamkeit von makrophagen und verfahren zu deren herstellung.
DE68920321D1 (de) Verfahren zur herstellung eines menschlichen "neutrophil chemotactic factor"-polypeptids.
ATE154608T1 (de) Verwendung einer mischung von peptiden and aminosäuren für die prophylaxis oder behandlung von dementia
KR950704358A (ko) 카텝신 l 특이적 저해 폴리펩티드
EP0287997A3 (de) Des-19-leucine, 20-glutamin, 21-threonine calcitonin
EP0290029A3 (de) (19-Alanin)-calcitonin
DE69024839D1 (de) Retro-Inverso-Peptide, Analoga von Thymopenthin, die eine oder mehrere Bindungen tragen, Verfahren zu deren Herstellung und deren Verwendung zur Zubereitung eines Medikamentes
Sisto et al. Biologically active retro-inverted analogues of thymopentin (TP5)

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time